Thérèse Phillips

Development of an Automated PD-L1 Immunohistochemistry (IHC) Assay for Non–Small Cell Lung Cancer

Thérèse Phillips, Pauline Simmons, H. David Inzunza et al. · Applied immunohistochemistry & molecular morphology · 2015 · 192 citations · Full text

Medicine, Immunology, Oncology +17

Association of tumor PD-L1 expression and immune biomarkers with clinical activity in patients (pts) with advanced solid tumors treated with nivolumab (anti-PD-1; BMS-936558; ONO-4538).

Joseph F. Grosso, Christine E. Horak, David Inzunza et al. · Journal of Clinical Oncology · 2013 · 159 citations

Life Sciences, Immunology, Oncology +17

Development of Standard Estrogen and Progesterone Receptor Immunohistochemical Assays for Selection of Patients for Antihormonal Therapy

Thérèse Phillips, Gretchen Murray, Karen Wakamiya et al. · Applied immunohistochemistry & molecular morphology · 2007 · 89 citations

Medicine, Endocrinology, Oncology +17

Development of a Diagnostic Programmed Cell Death 1-Ligand 1 Immunohistochemistry Assay for Nivolumab Therapy in Melanoma

Thérèse Phillips, Molly M. Millett, Xiaoling Zhang et al. · Applied immunohistochemistry & molecular morphology · 2017 · 34 citations · Full text

Life Sciences, Immunology, Oncology +17

Programmed death-ligand 1 (PD-L1) expression in various tumor types

Joseph F. Grosso, David Inzunza, Qiuyan Wu et al. · Journal for ImmunoTherapy of Cancer · 2013 · 28 citations · Full text

Life Sciences, Immunology, Tumor Microenvironment +1